Literature DB >> 29410130

Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome.

Andrey G Tereshchenkov1, Malgorzata Dobosz-Bartoszek2, Ilya A Osterman3, James Marks4, Vasilina A Sergeeva1, Pavel Kasatsky5, Ekaterina S Komarova6, Andrey N Stavrianidi1, Igor A Rodin1, Andrey L Konevega7, Petr V Sergiev3, Natalia V Sumbatyan1, Alexander S Mankin4, Alexey A Bogdanov8, Yury S Polikanov9.   

Abstract

Antibiotic chloramphenicol (CHL) binds with a moderate affinity at the peptidyl transferase center of the bacterial ribosome and inhibits peptide bond formation. As an approach for modifying and potentially improving properties of this inhibitor, we explored ribosome binding and inhibitory activity of a number of amino acid analogs of CHL. The L-histidyl analog binds to the ribosome with the affinity exceeding that of CHL by 10 fold. Several of the newly synthesized analogs were able to inhibit protein synthesis and exhibited the mode of action that was distinct from the action of CHL. However, the inhibitory properties of the semi-synthetic CHL analogs did not correlate with their affinity and in general, the amino acid analogs of CHL were less active inhibitors of translation in comparison with the original antibiotic. The X-ray crystal structures of the Thermus thermophilus 70S ribosome in complex with three semi-synthetic analogs showed that CHL derivatives bind at the peptidyl transferase center, where the aminoacyl moiety of the tested compounds established idiosyncratic interactions with rRNA. Although still fairly inefficient inhibitors of translation, the synthesized compounds represent promising chemical scaffolds that target the peptidyl transferase center of the ribosome and potentially are suitable for further exploration.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  X-ray structure; antibiotic; peptidyl transferase center; protein synthesis; ribosome

Mesh:

Substances:

Year:  2018        PMID: 29410130      PMCID: PMC6023675          DOI: 10.1016/j.jmb.2018.01.016

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  43 in total

1.  Effective cotranslational folding of firefly luciferase without chaperones of the Hsp70 family.

Authors:  Maxim S Svetlov; Aigar Kommer; Vyacheslav A Kolb; Alexander S Spirin
Journal:  Protein Sci       Date:  2005-12-29       Impact factor: 6.725

2.  Tools for characterizing bacterial protein synthesis inhibitors.

Authors:  Cédric Orelle; Skylar Carlson; Bindiya Kaushal; Mashal M Almutairi; Haipeng Liu; Anna Ochabowicz; Selwyn Quan; Van Cuong Pham; Catherine L Squires; Brian T Murphy; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

3.  Molecular mechanism of drug-dependent ribosome stalling.

Authors:  Nora Vazquez-Laslop; Celine Thum; Alexander S Mankin
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

Review 4.  Mitochondrial translational inhibitors in the pharmacopeia.

Authors:  Bruce H Cohen; Russell P Saneto
Journal:  Biochim Biophys Acta       Date:  2012-03-06

5.  Antibiotics: where to throw the spanner in the ribosomal machinery?

Authors:  Samuel A McKie
Journal:  Future Med Chem       Date:  2016-09-21       Impact factor: 3.808

6.  Binding of chloramphenicol to ribosomes. The effect of a number of antibiotics.

Authors:  D Vazquez
Journal:  Biochim Biophys Acta       Date:  1966-02-21

7.  Dual effect of chloramphenicol peptides on ribosome inhibition.

Authors:  Anthony Bougas; Ioannis A Vlachogiannis; Dimitrios Gatos; Stefan Arenz; George P Dinos
Journal:  Amino Acids       Date:  2017-03-10       Impact factor: 3.520

8.  Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms.

Authors:  B T Porse; R A Garrett
Journal:  J Mol Biol       Date:  1999-02-19       Impact factor: 5.469

Review 9.  Tedizolid for the management of human infections: in vitro characteristics.

Authors:  Jeffrey B Locke; Gary E Zurenko; Karen Joy Shaw; Kenneth Bartizal
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

10.  How hibernation factors RMF, HPF, and YfiA turn off protein synthesis.

Authors:  Yury S Polikanov; Gregor M Blaha; Thomas A Steitz
Journal:  Science       Date:  2012-05-18       Impact factor: 47.728

View more
  14 in total

1.  Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol.

Authors:  Egor A Syroegin; Laurin Flemmich; Dorota Klepacki; Nora Vazquez-Laslop; Ronald Micura; Yury S Polikanov
Journal:  Nat Struct Mol Biol       Date:  2022-02-14       Impact factor: 18.361

2.  Structure of an engineered multidrug transporter MdfA reveals the molecular basis for substrate recognition.

Authors:  Hsin-Hui Wu; Jindrich Symersky; Min Lu
Journal:  Commun Biol       Date:  2019-06-17

3.  High-resolution crystal structures of ribosome-bound chloramphenicol and erythromycin provide the ultimate basis for their competition.

Authors:  Maxim S Svetlov; Elena Plessa; Chih-Wei Chen; Anthony Bougas; Marios G Krokidis; George P Dinos; Yury S Polikanov
Journal:  RNA       Date:  2019-02-07       Impact factor: 4.942

4.  New Chloramphenicol Derivatives from the Viewpoint of Anticancer and Antimicrobial Activity.

Authors:  Panagiota C Giannopoulou; Dionissia A Missiri; Georgia G Kournoutou; Eleni Sazakli; Georgios E Papadopoulos; Dionissios Papaioannou; George P Dinos; Constantinos M Athanassopoulos; Dimitrios L Kalpaxis
Journal:  Antibiotics (Basel)       Date:  2019-01-29

Review 5.  Translational control of antibiotic resistance.

Authors:  Anne Witzky; Rodney Tollerson; Michael Ibba
Journal:  Open Biol       Date:  2019-07-10       Impact factor: 6.411

6.  Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition.

Authors:  Dmitrii Y Travin; Zoe L Watson; Mikhail Metelev; Fred R Ward; Ilya A Osterman; Irina M Khven; Nelli F Khabibullina; Marina Serebryakova; Peter Mergaert; Yury S Polikanov; Jamie H D Cate; Konstantin Severinov
Journal:  Nat Commun       Date:  2019-10-08       Impact factor: 14.919

Review 7.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

Review 8.  Ribosome Rescue Pathways in Bacteria.

Authors:  Claudia Müller; Caillan Crowe-McAuliffe; Daniel N Wilson
Journal:  Front Microbiol       Date:  2021-03-18       Impact factor: 5.640

9.  Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the E. coli 70S ribosome.

Authors:  Evgeny B Pichkur; Alena Paleskava; Andrey G Tereshchenkov; Pavel Kasatsky; Ekaterina S Komarova; Dmitrii I Shiriaev; Alexey A Bogdanov; Olga A Dontsova; Ilya A Osterman; Petr V Sergiev; Yury S Polikanov; Alexander G Myasnikov; Andrey L Konevega
Journal:  RNA       Date:  2020-03-06       Impact factor: 4.942

Review 10.  Selective regulation in ribosome biogenesis and protein production for efficient viral translation.

Authors:  Hui-Jun Dong; Rui Zhang; Yu Kuang; Xiao-Jia Wang
Journal:  Arch Microbiol       Date:  2020-10-29       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.